Alexandra C. Istl, MD, MPH, FRCSC, FSSO

Publications

• ASO Author Reflections: Opportunities to Mitigate Cancer Disparities in Transgender and Gender-Diverse Populations.

  (Istl AC, Lawton S, Cortina CS.) Ann Surg Oncol. 2024 Sep;31(9):5587-5588 PMID: 38874873 PMCID: PMC11309883 SCOPUS ID: 2-s2.0-85196082480 06/14/2024

• ASO Visual Abstract: Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients.

  (Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS.) Ann Surg Oncol. 2024 Sep;31(9):5591-5592 PMID: 38864983 SCOPUS ID: 2-s2.0-85195645715 06/12/2024

• Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients.

  (Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS.) Ann Surg Oncol. 2024 Sep;31(9):5560-5569 PMID: 38861206 PMCID: PMC11309885 SCOPUS ID: 2-s2.0-85195645715 06/11/2024

• Primary Tumor Resection in Leiomyosarcoma Patients With Synchronous Isolated Lung Metastases: A National Cancer Database Study.

  (Istl AC, Nudotor R, Greer JB, Gross JM, Meyer CF, Johnston FM.) J Surg Res. 2024 Aug;300:559-566 PMID: 38925091 06/27/2024

• Treatment patterns and outcomes for primary uterine leiomyosarcoma with synchronous isolated lung metastases: A National Cancer Database study of primary resection and metastasectomy.

  (Istl AC, Desravines N, Nudotor R, Stone R, Greer JB, Meyer CF, Johnston FM.) Gynecol Oncol Rep. 2024 Feb;51:101308 PMID: 38174328 PMCID: PMC10758710 01/04/2024

• Skin in the Game: Surgical delays in our patients with melanoma.

  (Istl AC.) Am J Surg. 2024 Feb;228:299-300 PMID: 37743216 09/25/2023

• Pride & prejudice: A scoping review of LGBTQ + medical trainee experiences.

  (Sorgini A, Istl AC, Downie ML, Kirpalani A.) Med Teach. 2024 Jan;46(1):73-81 PMID: 37418565 07/07/2023

• Reduced to My Race Once Again: Perceptions about Underrepresented Minority Medical School Applicants in Canada and the United States.

  (Barootes HC, Huynh AC, Maracle M, Istl AC, Wang P, Kirpalani A.) Teach Learn Med. 2024;36(1):1-12 PMID: 36351290 11/10/2022

• PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies.

  (Lin KX, Istl AC, Quan D, Skaro A, Tang E, Zheng X.) Cancer Immunol Immunother. 2023 Dec;72(12):3875-3893 PMID: 37831146 PMCID: PMC10700246 10/13/2023

• Across the Twitter-verse: Is Twitter an equitable tool in academic medicine? A scoping review.

  (Istl AC, Verma S, Jawa NA, Mackin R, Seemann NM, Kirpalani A.) Adv Health Sci Educ Theory Pract. 2023 Aug;28(3):997-1013 PMID: 36637702 01/14/2023

• Comparative In Silico Analysis of Ultra-Hypofractionated Intensity-Modulated Photon Radiotherapy (IMRT) Versus Intensity-Modulated Proton Therapy (IMPT) in the Pre-Operative Treatment of Retroperitoneal Sarcoma.

  (Gogineni E, Chen H, Istl AC, Johnston FM, Narang A, Deville C Jr.) Cancers (Basel). 2023 Jul 04;15(13) PMID: 37444592 PMCID: PMC10341304 07/14/2023

• Impact of Frailty Upon Surgical Decision-Making for Left-Sided Colon Cancer.

  (Sibia US, Badve SB, Istl AC, Klune JR, Riker AI.) Ochsner J. 2023;23(2):120-128 PMID: 37323515 PMCID: PMC10262939 06/16/2023